EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
11.01
+0.26 (2.42%)
At close: Aug 13, 2025, 4:00 PM
11.20
+0.19 (1.72%)
Pre-market: Aug 14, 2025, 8:05 AM EDT
EyePoint Pharmaceuticals Employees
EyePoint Pharmaceuticals had 165 employees as of December 31, 2024. The number of employees increased by 44 or 36.36% compared to the previous year.
Employees
165
Change (1Y)
44
Growth (1Y)
36.36%
Revenue / Employee
$314,533
Profits / Employee
-$1,062,915
Market Cap
758.89M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EYPT News
- 7 days ago - EyePoint Pharmaceuticals, Inc. (EYPT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - EyePoint to Present at the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 8 days ago - EyePoint Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Developments - GlobeNewsWire
- 15 days ago - EyePoint to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 16 days ago - EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration - GlobeNewsWire
- 4 weeks ago - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - EyePoint Stock: Retaining My 'Risky Buy' Call - Pivotal Data Due Early 2026 - Seeking Alpha
- 2 months ago - EyePoint Announces Participation at Upcoming Investor Conferences - GlobeNewsWire